Europe Protein Engineering Market

Europe Protein Engineering Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, and Software & Services), By End-use, By Technology, By Protein Type, By Country and Growth Forecast, 2024 - 2031

Report Id: KBV-23186 Publication Date: June-2024 Number of Pages: 148
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Europe Protein Engineering Market would witness market growth of 15.6% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Protein Engineering Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $512.2 million by 2031. The UK market is exhibiting a CAGR of 14.6% during (2024 - 2031). Additionally, The France market would experience a CAGR of 16.9% during (2024 - 2031).

Europe Protein Engineering Market

Protein engineering advancements have been of great benefit to the healthcare industry, which is one of the primary beneficiaries. Therapeutic proteins, including cytokines, monoclonal antibodies, and vaccines, have brought about a paradigm shift in the management of numerous ailments, including infectious diseases, cancer, and autoimmune disorders.

Beyond therapeutic proteins, this engineering is also pivotal in the design of novel diagnostics and biosensors. These engineered proteins can be tailored to recognize specific biomarkers or environmental contaminants, enabling the development of highly sensitive and specific diagnostic tools.

Germany is home to several leading pharmaceutical companies and research institutions investing in this engineering to develop novel therapeutics and diagnostics. According to the Germany Trade & Invest, healthcare spending in Germany exceeded EUR 457 billion in 2021. This growth has partly driven the advancements in the engineering technologies and their application in drug discovery and development. Likewise, In France, the demand for this engineering is driven by increasing investment in research and innovation. The French government has been promoting research and development through initiatives such as the National Research Agency (ANR), which provides funding for innovative research projects. As the first year of implementation for the new three-year ANR Work Programme, 2022 saw the selection of more than 2,000 research projects, with a budget of €1.1 billion, supporting a wide range of research areas, including this engineering. This investment has led to a growing number of research institutions and companies engaged in engineering research. Thus, the demand for this engineering in Europe is driven by expanding research and innovation initiatives, strong pharmaceutical and biotechnology industries, and increasing investment in research and development.

Free Valuable Insights: The Global Protein Engineering Market will Hit USD 7.8 Billion by 2031, at a CAGR of 16.0%

Based on Product, the market is segmented into Instruments, Reagents, and Software & Services. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic Research Institutes. Based on Technology, the market is segmented into Rational Protein Design, Hybrid Approach, Directed Evolution, De Novo Protein Design, and Others. Based on Protein Type, the market is segmented into Monoclonal Antibodies, Insulin, Vaccines, Growth Factors, Interferon, Colony Stimulating Factors, Coagulation Factors, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

List of Key Companies Profiled

  • Agilent Technologies, Inc.
  • Bruker Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Genscript Biotech Corporation
  • Amgen, Inc.
  • Promega Corporation

Europe Protein Engineering Market Report Segmentation

By Product

  • Instruments
  • Reagents
  • Software & Services

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic Research Institutes

By Technology

  • Rational Protein Design
  • Hybrid Approach
  • Directed Evolution
  • De Novo Protein Design
  • Others

By Protein Type

  • Monoclonal Antibodies
  • Insulin
  • Vaccines
  • Growth Factors
  • Interferon
  • Colony Stimulating Factors
  • Coagulation Factors
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo